Apollo Hospitals to Invest INR 250 Cr in India's First Proteus One Proton Therapy System
This initiative aims to enhance Apollo's existing proton therapy capacity, which currently treats more than 500 patients annually at its Chennai center, designed to accommodate 850 patients. The new facility will provide treatment for an additional 350 patients each year.
Apollo Hospitals Enterprise has announced plans to establish a comprehensive oncology center featuring India's first Proteus One proton therapy system, with an investment of INR 250 Cr over the next three years.
The facility will be located in Hyderabad and is expected to become operational by FY2028.
This initiative aims to enhance Apollo's existing proton therapy capacity, which currently treats more than 500 patients annually at its Chennai center, designed to accommodate 850 patients. The new facility will provide treatment for an additional 350 patients each year.
Dr Prathap C Reddy, Founder-Chairman, Apollo Hospitals Enterprise, said, "The addition of Proteus One to our Apollo Proton Cancer Centres further solidifies our position as a global leader in proton therapy. This next-generation technology will allow us to achieve superior clinical outcomes and significantly improve the quality of life for cancer patients in India and beyond."
Funding for the project will be sourced from internal accruals. Apollo Hospitals has entered into a partnership with Ion Beam Applications (IBA), a leading provider of proton beam therapy solutions, to implement the Proteus One system in India.
Apollo first introduced proton therapy in 2019 at its Chennai center, which is currently the only facility of its kind in South Asia and the Middle East. The advanced treatment is utilized for various complex cancers, including those affecting the central nervous system, head and neck, as well as pediatric and urological cancers.
